InvestorsHub Logo
Followers 378
Posts 20728
Boards Moderated 2
Alias Born 03/28/2010

Re: None

Wednesday, 04/20/2011 12:13:53 AM

Wednesday, April 20, 2011 12:13:53 AM

Post# of 4164
Compensated Awareness Post View Disclaimer
$NFRM is pleased to obtain the exclusive license to the technology on worldwide basis for GLB333. The product that has considerable data already, will be ready for clinical trials Phase I/II in near future," said Elaine Affleck, President of National Pharmaceuticals Corp. http://t.co/6g3n3KI 03/22/11

~Always do you own DD~~~If I QUOTED
you in my reply...You have been TWEET blasted Diva Style by the
HARLEY chick :)STOCKSDIVA BIO BIN BOARD